European Pharmaceutical Review

FEBRUARY 20, 2025

For instance, in the EU, 46 percent of generic medicines from the EU Critical List of Medicines are provided by a single supplier. For these firms with over 60 percent market share, this number rises to 83 percent of critical generic medicines, according to the data.

Generic Medicine 59

Generic Medicine Patient Care 59

STAT

APRIL 30, 2024

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that period, according to a new analysis.

Labelling 113

Labelling Generic Medicine 113

Fierce Pharma

JULY 22, 2024

drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat. . | As lawmakers and industry groups seek to get a handle on U.S.

Generic Medicine 127

Generic Medicine 127

STAT

SEPTEMBER 18, 2024

patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis.  Amid debate over potential abuse of the U.S.

Generic Medicine 143

Generic Medicine 143

pharmaphorum

FEBRUARY 15, 2024

The FTC is investigating wholesalers and other middlemen in the pharma supply chain to assess their possible role in worsening shortages of generic medicines

Generic Medicine 113

Generic Medicine 113

STAT

FEBRUARY 5, 2024

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Generic Medicine 145

Generic Medicine Insurance 145

STAT

JANUARY 5, 2024

As a former editor for diabetes publications, I knew that insurance companies regularly switched people from one brand of insulin to another, or from a name brand of insulin to a generic. However, I had used generic medicine for my blood pressure without a problem, so I hoped for the best with this switch.

Insurance 127

Insurance Generic Medicine 127

The Guardian - Pharmaceutical Industry

JANUARY 22, 2024

Roared on by the pharmaceutical industry, ministers have been using trade talks with India to push for agreement on new, extremely restrictive patent rules that would severely undermine its generic medicines industry.

Generic Medicine 107

Generic Medicine 107

STAT

DECEMBER 4, 2024

Specifically, the proposed rule was crafted to stem the use of so-called patent thickets , which are wielded by drug companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 118

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 118

STAT

JUNE 17, 2024

Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets , which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.

Generic Medicine 129

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 129

STAT

SEPTEMBER 19, 2024

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

Documentation 116

Documentation FDA Generic Medicine 116

STAT

SEPTEMBER 14, 2023

In explaining its new policy statement , the FTC noted that some drug companies have failed to follow requirements for listing patents in the so-called Orange Book in hopes of thwarting competition from lower-cost generic medicines.

Generic Medicine 131

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies FDA 131

STAT

SEPTEMBER 29, 2023

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

Generic Medicine 116

Generic Medicine 116

STAT

MARCH 1, 2024

A growing number of alternative pharmacies — such as those run by Costco, Amazon, and Mark Cuban Cost Plus Drugs — may be increasingly popular with American consumers, but a new analysis finds many of the most expensive generic medicines are unavailable, prices vary widely, and savings can be modest.

Generic Medicine 121

Generic Medicine 121

STAT

NOVEMBER 7, 2023

The move comes two months after the FTC issued a policy statement noting some drug companies have failed to follow requirements for listing patents in the Food and Drug Administration’s Orange Book in hopes of thwarting competition from lower-cost generic medicines. Continue to STAT+ to read the full story…

Generic Medicine 121

Generic Medicine 121

STAT

NOVEMBER 3, 2022

A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.

Generic Medicine 100

Generic Medicine 100

STAT

MARCH 21, 2023

A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world. More than 200 civil society and patient advocacy groups are urging the U.K. Now, the groups are upset that the involvement of Harjinder Kang, the U.K.

Generic Medicine 99

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 99

STAT

FEBRUARY 10, 2023

WASHINGTON — Generic drugmakers lobbied hard against Democrats’ new law empowering Medicare to negotiate prescription drug prices. Giving the government such power seemed like an admission that generic medicines don’t do enough to keep costs down.

Generic Medicine 97

Generic Medicine Packaging 97

STAT

MAY 23, 2023

But it’s a generic medicine — which means PBMs’ negotiating techniques don’t apply. Generic drugs compete on price. There’s just one problem: PBMs don’t have anything to do with that discrepancy. The chemo drug in question, Imatinib, costs $17,000 at CVS and just $72 at Cost Plus Drugs.

Generic Medicine 98

Generic Medicine 98

pharmaphorum

JUNE 19, 2024

Amazon Pharmacy is expanding its subscription service for generic medicines, making it available to Medicare patients

Generic Medicine 69

Generic Medicine 69

STAT

JULY 21, 2023

The review comes in response to an inspection of Synapse facilities by Spanish regulators, who raised “serious concerns about the validity and reliability” of clinical trial data generated by the company.

Generic Medicine 98

Generic Medicine FDA 98

The Guardian - Pharmaceutical Industry

AUGUST 15, 2023

Indian Medical Association says that testing is substandard in the manufacture of generic medicines with ‘no guarantee of quality’ Indian doctors have been told they can no longer prescribe branded drugs for their patients, provoking vehement protest from the Indian Medical Association [IMA].

Generic Medicine 75

Generic Medicine 75

Pharmaceutical Technology

DECEMBER 15, 2022

Europe also enforces rigid pricing policies for essential medicines to be available at the lowest possible price. These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.

Generic Medicine 98

Generic Medicine Hospitals 98

Fierce Pharma

SEPTEMBER 19, 2023

Two large Indian suppliers of generic medicines in the U.S. and beyond are at the center of the industry's M&A rumor mill this week. Torrent is looking for financial help to potentially make a bid for its larger rival Cipla, according to Reuters.

Generic Medicine 57

Generic Medicine 57

European Pharmaceutical Review

JANUARY 30, 2024

Ryzneuta (efbemalenograstim alfa) received a positive opinion from the CHMP as a medicine to reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Generic Medicine 98

Generic Medicine Chemotherapy Hospitals 98

European Pharmaceutical Review

MARCH 14, 2023

The CJEU stressed that identical medicinal products are not those that are only therapeutically equivalent (as generics are to reference products), but they should be identical in all respects.

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

pharmaphorum

MARCH 14, 2022

For Sandoz, the acquisition gives it a technology platform in an area of the generic medicines market with a relatively high barrier to entry, as developing inhaled medicines poses “comparatively high technical complexity,” according to Sandoz chief executive Richard Saynor.

Generic Medicine 104

Generic Medicine 104

pharmaphorum

OCTOBER 6, 2022

” It also sees continued growth in cardiovascular and venous diseases, as well as in generic medicines, and says its new visual identity (see above) reflects its “uniqueness” as an “independent group, governed by a foundation, committed to therapeutic progress to serve patient needs.”

Generic Medicine 98

Generic Medicine Chemotherapy 98

pharmaphorum

JANUARY 13, 2022

Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report.

Payment Processing 111

Payment Processing Generic Medicine Insurance Hospitals 111

pharmaphorum

JANUARY 30, 2023

With the production of generic medicine being concentrated in China and India, the ability to flexibly influence the supply of generic medicine, which most antibiotics are, is relatively limited. Larger questions remain around the way in which to support manufacturers to invest in production capabilities for antibiotics.

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

European Pharmaceutical Review

AUGUST 25, 2022

Meanwhile, Sandoz would leverage its strong brand and sustain its leading global position by continuing to invest in the key strategic areas of Biosimilars, Antibiotics and Generic Medicines. Working to deliver on its vision of access to patients. Additional transaction details.

Generic Medicine 98

Generic Medicine 98

European Pharmaceutical Review

JANUARY 30, 2023

Four new medicines recommended for approval The CHMP recommended granting a marketing authorisation for Sotyktu (deucravacitinib) for the treatment of moderate to severe plaque psoriasis in adults. Sitagliptin/Metformin hydrochloride Sun (sitagliptin/metformin hydrochloride) for the treatment of type 2 diabetes mellitus.

Generic Medicine 96

Generic Medicine 96

Pharmaceutical Technology

FEBRUARY 28, 2023

The company offers generic medicines and biosimilars through Sandoz. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others.

Generic Medicine 68

Generic Medicine Immunization 68

European Pharmaceutical Review

JULY 25, 2023

The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines.

Compounding 97

Compounding Generic Medicine 97

Pharmaceutical Technology

AUGUST 26, 2022

Last year, Sandoz generated sales worth $9.6bn and served more than 100 markets across the globe with a robust presence in the US, Europe and other regions. Upon becoming a standalone company, Sandoz would progress to make investments in the main strategic regions of antibiotics, biosimilars and generic medicines.

Generic Medicine 59

Generic Medicine 59

pharmaphorum

OCTOBER 26, 2021

We certainly have a problem with national-level procurement policies that put almost no value on generic medicines … that approach needs to change. The rather inflexible, old-fashioned regulatory regime in Europe should be modernised in order to attract investment, and to improve agility and flexibility.”.

Generic Medicine 121

Generic Medicine 121

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US.

Generic Medicine 59

Generic Medicine FDA 59